Skip to main content

UBS Group AG

Position in MNPR — Monopar Therapeutics

CIK 1610520 ZURICH, V8

Position in MNPR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,523,910
+$363,212 QoQ
Shares Held
27,259
-30.9% QoQ
Ownership
0.406%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 95 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MNPR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. MNPR ranks #198 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in MNPR

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,523,910 27,259
2026-03-31 $2,160,698 39,436
2025-12-31 $277,524 4,250
2025-09-30 $651,154 7,973
2025-06-30 $782,615 21,873
2025-03-31 $295,684 8,121
2024-12-31 $141,306 6,423
2024-09-30 $3,450 512
2024-03-31 $1,748 2,568
2023-12-31 $4,045 11,899
2023-09-30 $44 72
2023-03-31 $8,879 6,388
2022-12-31 $7,474 3,154
2022-09-30 $8,206 5,399
2022-06-30 $44,990 19,561
2022-03-31 $7,920 3,106
2021-12-31 $9,845 3,067
2021-03-31 $3,540 571
2020-12-31 $5,826 952
2020-03-31 $107 15